Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review

Ryan M Kahn1, Sushmita Gordhandas1, Kendra Godwin2

  • 1Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

JAMA Surgery
|September 6, 2023
PubMed
Abstract

Insights

Opportunistic salpingectomy, the removal of fallopian tubes, significantly reduces ovarian cancer risk by approximately 80%. This safe and cost-effective procedure offers a promising strategy for preventing ovarian cancer and reducing mortality rates.

Area of Science:

  • Gynecologic Oncology
  • Preventive Medicine
  • Surgical Innovation

Background:

  • Epithelial ovarian cancer predominantly originates in the fallopian tubes.
  • Opportunistic salpingectomy is proposed as a preventive measure for average-risk women.

Approach:

  • A systematic review adhering to PRISMA 2020 guidelines was conducted.
  • Searched four major databases (PubMed, Embase, CENTRAL, Northern Light) and 20 gray literature sources.
  • Included 158 publications from an initial 1089 results.

Key Points:

  • Salpingectomy is associated with an ~80% reduction in ovarian cancer risk.
  • The procedure is safe, cost-effective, and does not hasten menopause.
  • Widespread implementation could decrease US ovarian cancer mortality by ~15%.

Conclusions:

  • Bilateral salpingectomy is a safe, feasible, and potentially cost-saving strategy for ovarian cancer prevention.
  • Increased awareness of the adnexa's role in ovarian cancer and salpingectomy benefits is crucial.
  • Further prospective studies are needed to confirm long-term survival and feasibility in non-gynecologic surgeries.